Initial Staging of Malignant Melanoma by Positron Emission Tomography and Sentinel Node Biopsy

References

• Cascinelli N., Morabito A., Santinami M., Mackie R. M., Belli I. F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet, 1998, 351: 793–6.
   Google Scholar
• Landis S. H., Murray T., Bolden S., Wingo P. A. Cancer statistics, 1999. CA Cane J Clin, 1999, 49: 8–31.
   Google Scholar
• E, Del Bajetta Vecchio M., Bernard-Marty e. et al. Metastatic melanoma: Chemotherapy. Semin Oncol, 2002, 29: 427–45.
   Google Scholar
• Balch e. M., Soong S. J., Gershenwald J. E. et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer Melanoma Staging System. J Clin Oncol, 2001, 19: 3622–34.
   Google Scholar
• Balch e. M., Buzaid A. C., Soong S. J. et al. Final version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol, 2001, 19: 3635–48.
   Google Scholar
• Cobben D. C. P., Koopal S., Tiebosch A. T. M. G. et al. New diagnostic techniques in staging in the surgical treatment of cutaneous malignant melanoma. Eur J Surg Oncol, 2002, 28: 692–700.
   Google Scholar
• Veronesi U., Adamus J., Bandiera D. C. et al. Delayed regional lymph node dissection in stage i melanoma of the skin of the lower extremities. Cancer, 1982, 49: 2420–30.
   Google Scholar
• Slinguff C. L., Stidham K. R., Ricci W. M., Stanley W. E., Seigler H. F. Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients. Ann Surg, 1994, 219: 120–30.
   Google Scholar
• Lens M. B., Dawes M., Goodacre T., Newton-Bishop J. A. Elective lymph node dissection in patients with melanoma. Systematic review and meta-analysis of randomized controlled trials. Arch Surg, 2002, 137: 458–61.
   Google Scholar
• Milton G. W., Shaw H. M., McCarthy W. H., Pearson L., Balch C. M., Soong S. J. Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg, 1982, 69: 108–11.
   Google Scholar
• Drepper H., Kohler C. O., Bastian B. et al. Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients. Cancer, 1993, 72: 741–9.
   Google Scholar
• Balch C. M., Soong S. J., Bartolucci A. A. et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg, 1996, 224: 255–66.
   Google Scholar
• Reintgen D. S., Cox E. B., McCarty K. S., Vollmer R. T., Seigler H. F. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg, 1983, 198: 379–85.
   Google Scholar
• McMasters K. M., Reintgen D. S., Ross M. I. et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol, 2001, 19: 2851–5.
   Google Scholar
• Wagner J. D., Schauwecker D., Hutchins G., Coleman J. J. 3rd. initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma. J Surg Oncol, 1997, 64: 181–9.
   Google Scholar
• Macfarlane D. J., Sondak V., Johnson T., Wahl R. L. Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma. J Clin Oncol, 1998, 16: 1770–6.
   Google Scholar
• Havenga K., Cobben D. C. P., Oyen W. J. G. et al. Fluoro-deoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma. Eur J Surg Oncol, 2003, 29: 662–4.
   Google Scholar
• Wagner J. D., Schauwecker D., Davidson D. et al. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. J Clin Oncol, 1999, 17: 1508–15.
   Google Scholar
• Acland K. M., Healy C., Calonje E. et al. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma. J Clin Oncol, 2001, 19: 2674–8.
   Google Scholar
• Belhocine T., Pierard G., De Labrassine M., Lahaye T., Rigo P. Staging of regional lymph nodes in AJCC stage I and II melanoma: 18-FDG PET imaging versus sentinel node detection. The Oncologist, 2002, 7: 271–8.
   Google Scholar
• Mijnhout G. S., Hoekstra O. S., Van Lingen A. et al. How mor-phometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma. J Clin Pathol, 2003, 56: 283–6.
   Google Scholar
• Wagner J. D., Davidson D., Coleman J. J. 3rd et al. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol, 1999, 6: 398–404.
   Google Scholar
• Crippa F., Leutner M., Belli F. et al. Which kinds of lymph node metastases can FDG PET detect ? A clinical study in melanoma. J Nucl Med, 2000, 41: 1491–4.
   Google Scholar
• Steinert H. C., Huch Boni R. A., Buck A. et al. Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology, 1995, 195: 705–9.
   Google Scholar
• Rinne D., Baum R. P., Hor G., Kaufmann R. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography. Results of a prospective study of 100 patients. Cancer, 1998, 82: 1664–71.
   Google Scholar
• Holder W. D., White R. L., Zuger J. H., Easton E. J., Greene F. L. Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg, 1998, 227: 764–71.
   Google Scholar
• Eigtveld A., Andersson A. P., Dahlstrom K. et al. Use of fluo-rine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma. Eur J Nucl Med, 2000, 27: 70–5.
   Google Scholar
• Pritchard R. S., Hill A. D. K., Skehan S. J., O’Higgins N. J. Positron emission tomography for staging and management of malignant melanoma. Br J Surg, 2002, 89: 389–96.
   Google Scholar
• Morton D. L., Wen D. R., Wong J. H. et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg, 1992, 127: 392–9.
   Google Scholar
• Reintgen D., Cruse C. W., Wells K. et al. The orderly progression of melanoma nodal metastases. Ann Surg, 1994, 220: 759–67.
   Google Scholar
• Borgstein P., Meijer S. Historical perspective of lymphatic tumour spread and the emergence of the sentinel node concept. Eur J Surg Oncol, 1998, 24: 85–95.
   Google Scholar
• Nieweg O. E., Tanis P. J., Rutgers E. J. T. Summary of the Second International Sentinel Node Conference. Eur J Nucl Med, 2001, 28: 646–9.
   Google Scholar
• Gennari R., Bartolomei M., Testori A. et al. Sentinel node localization in primary melanoma: Preoperative dynamic lympho-scintigraphy, intraoperative gamma probe, and vital dye guidance. Surgery, 2000, 127: 19–25.
   Google Scholar
• Jacobs I. A., Chevinsky A. H., Swayne L. C., Magidspn J. G., Britto E. J., Smith T. J. Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: Reliability of the procedure and analysis of failures after longterm follow-up. J Surg Oncol, 2001, 77: 157–64.
   Google Scholar
• Krag D. N., Meijer S. J., Weaver D. L. et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg, 1995, 130: 654–8.
   Google Scholar
• Pijpers R., Borgstein P. J., Meijer S., Hoekstra O. S., Van Hattum L. H., Teule G. J. J. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg, 1997, 21: 788–92.
   Google Scholar
• Pu L. L. Q., Cruse C. W., Wells K. E. et al. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. Plast Reconstr Surg, 1999, 104: 964–9.
   Google Scholar
• Morton D. L., Thompson J. F., Essner R. et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lym-phadenectomy for early-stage melanoma. A multicenter trial. Ann Surg, 1999, 230: 453–65.
   Google Scholar
• Muller M. G. S., Borgstein P. J., Pijpers R. et al. Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up. Ann Surg Oncol, 2000, 7: 4618.
   Google Scholar
• Messina J. L., Glass L. F., Cruse C. W., Berman C., Ku N. K., Reintgen D. S. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol, 1999, 23: 686–90.
   Google Scholar
• Gershenwald J. E., Colome M. I., Lee J. E. et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage i or ii melanoma. J Clin Oncol, 1998, 16: 2253–60.
   Google Scholar
• Gado M. A., Cosimi A. B., Yu J. et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg, 1999, 134: 381–7.
   Google Scholar
• Jansen L., Nieweg O. E., Peterse J. L., Hoefnagel C. A., Valdes Olmos R. A., Kroon B. B. R. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg, 2000, 87: 484–9.
   Google Scholar
• Cascinelli N., Belli F., Santinami M. et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO melanoma program experience. Ann Surg Oncol, 2000, 7: 469–74.
   Google Scholar